Access Pharmaceuticals (OTC: ACCP.OB, “Access”) develops and commercializes products for the treatment and supportive care of cancer patients.
Browsing: prolindac
OneMedPlace recently interviewed CEO Jeffrey Davis about the Dallas-based company’s pipeline.